CLICKSEQ
Live / Applied — Statement of use — response to non-final action entered (as of 01 Oct 2026)
What this means for you
Not registered yet, but its 09 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98035641
- Mark type
- Word mark
- Filed
- 09 Jun 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Marina A. Lewis
Goods and services
- Class 001 — Chemicals: Reagents for scientific or medical research use and reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for scientific and research use; diagnostic reagents for clinical or medical research laboratory use, other than for medical or veterinary purposes and diagnostic reagent kits consisting primarily of buffers and reagents for clinical or medical research laboratory use, other than for medical or veterinary purposes; reagents for use in medical, genetic, and biotechnology research and reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in the medical research, genetic research, and biotechnology research
- Class 005 — Pharmaceuticals: Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for medical use; Medical diagnostic reagents for clinical or medical laboratory use and medical diagnostic reagent kits consisting primarily of buffers and reagents for clinical or medical laboratory use
- Class 042 — Scientific and technological services: DNA and RNA screening for scientific research purposes; DNA and RNA analysis services for scientific research purposes; DNA and RNA library services, namely, providing DNA and RNA sequencing technology research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Laboratory research services in the fields of DNA sequencing, RNA and DNA analysis, and genetic analysis; Scientific research consulting in the field of genetics; Scientific research in the field of genetics and genetic engineering; Scientific testing services, namely, identification and testing of DNA samples for research purposes; Design and development of computer hardware and software; Software as a service (SAAS) services featuring software that provides information and advice relating to genetics, genetic engineering, biomedical testing, DNA screening, and DNA and RNA analysis; Providing information, advisory and consultancy services in relation to scientific research in the field of genetics, DNA and RNA analysis, and biomedical testing
Owner
- ClickSeq Technologies, LLC, GALVESTON, TX, US
- ClickSeq Technologies, LLC, GALVESTON, TX, US
Prosecution history
- 01 Oct 2026 — AMENDMENT FROM APPLICANT ENTERED
- 01 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Oct 2026 — ASSIGNED TO LIE
- 28 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Jun 2026 — NON-FINAL ACTION E-MAILED
- 26 Jun 2026 — SU - NON-FINAL ACTION - WRITTEN
- 21 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Nov 2025 — USE AMENDMENT FILED
- 26 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 1 GRANTED
- 27 May 2025 — SOU EXTENSION 1 FILED
- 27 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT